Skip to content
★ Sign in to follow
Total declarations
2
Company
1
▲ Purchases (2 ops.)
€21k
▼ Sales (0 ops.)
—

Latest filing published 05 Sept 2007 for Ernexa Therapeutics Inc., €10k.

Insider track record

Disclosed buys
2
Disclosed sells
0
Signal history

No signal scores available.

Closed purchases

Market purchases
2

Not enough history yet: 1 closed purchase, at least 2 are needed.

Purchases by company

Since each purchase

  • Filed 05 Sept 2007 · 7005 days ago · €10k
    -76.1%
    Entry US$690,000.00 · Close at T+365 US$165,000.00

Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.

Jennifer Bourbiel: trading record in brief

All filings by Jennifer Bourbiel on record concern Ernexa Therapeutics Inc. We count 2 filings, every one of them for a trade on 31 August 2007.

No open-market sale appears; the market trades are 2 purchases worth €21k. Unlike grants, an open-market purchase is paid for by the insider, at the market price.

Most recently, on 6 September 2007, the filings show an open-market purchase worth €10k in Ernexa Therapeutics Inc. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.

Companies and markets linked to Jennifer Bourbiel

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations1 total
  • ▲
    Vice President, MarketingExecutivesErnexa Therapeutics Inc.
    14,100 USD0SEC
    15,000 shares@ US$0.94Common StockSEC:0001181431-07-056066:0
    Canonical exit: 29 Nov 2007 (T+90)

1 of 1 declaration